Unravelling the complexity of metastasis - molecular understanding and targeted therapies

Nilay Sethi1, Yibin Kang

  • 1Department of Molecular Biology, Washington Road, LTL 255, Princeton University, Princeton, New Jersey 08544, USA.

Nature Reviews. Cancer
|September 24, 2011
PubMed

Insights

Effective treatments for metastatic cancer remain elusive due to complex genomic changes and tumor-stromal interactions. New genomic and imaging technologies offer hope for understanding and targeting cancer spread to improve patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Cancer Biology

Background:

  • Metastasis, the spread of cancer, has devastating consequences but lacks effective treatments.
  • Late-stage cancers present complex genomic alterations and interactions between tumor and stromal cells, hindering understanding and control.
  • Current therapeutic strategies are insufficient for managing widespread metastatic disease.

Purpose of the Study:

  • To address the challenges in understanding and controlling metastatic cancer.
  • To explore how genomic and systems-level approaches can advance metastasis research.
  • To identify potential pathways for translating new knowledge into effective targeted therapies.

Main Methods:

  • Integration of genomic and systems-level analyses.
  • Application of advanced imaging technologies.
  • Utilization of innovative animal models for studying metastasis.

Main Results:

  • Genomic and systems-level approaches are galvanizing research into metastasis.
  • Technological breakthroughs in imaging and animal modeling are enhancing our understanding.
  • Significant progress is being made in overcoming knowledge gaps in metastatic disease.

Conclusions:

  • Despite challenges, advancements in technology and research approaches are improving our understanding of cancer metastasis.
  • Future research holds promise for developing novel targeted therapies to combat metastatic cancer.
  • Translating new knowledge into effective treatments is a key goal for improving patient outcomes in advanced cancers.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...